Marketing Death and Alzheimer’s Disease

Posted August 9, 2019 3:16 pm by Alex Schadenberg

Marketing Death and Alzheimer’s Disease

This article was written and published by Nancy Valko on August 9, 2019. Nancy ValkoBy Nancy ValkoAn April, 2019 study in the Journal of the American Medical Association titled “Attitudes Toward Physician-Assisted Death From Individuals Who Learn They Have an Alzheimer Disease Biomarker” found that approximately 20% of cognitively normal older adults who had elevated beta-amyloid — a biomarker that is thought to increase the risk of Alzheimer’s disease — said they would consider physician-assisted suicide if they experienced a cognitive decline. Not everyone with amyloid plaques goes on to develop Alzheimer’s disease. Although no state with legalized physician-assisted suicide

Read more... http://alexschadenberg.blogspot.com

Send this to a friend